董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Christopher Wolfe | 男 | Independent Director | 45 | 15.03万美元 | 未持股 | 2025-11-11 |
| Timothy R. Danker | 男 | Chief Executive Officer and Director | 51 | 348.75万美元 | 未持股 | 2025-11-11 |
| Donald Hawks III | 男 | Chairman of the Board and Independent Director | 49 | 22.50万美元 | 未持股 | 2025-11-11 |
| Earl Devanny III | 男 | Independent Director | 73 | 22.50万美元 | 未持股 | 2025-11-11 |
| Denise Devine | 女 | Independent Director | 69 | 24.50万美元 | 未持股 | 2025-11-11 |
| Raymond Weldon | 男 | Independent Director | 65 | 20.75万美元 | 未持股 | 2025-11-11 |
| Srdjan Vukovic | 男 | Independent Director | 43 | 15.03万美元 | 未持股 | 2025-11-11 |
| Kavita Patel | 女 | Independent Director | 51 | 21.50万美元 | 未持股 | 2025-11-11 |
| Srdjan Vukovic | 男 | Independent Director | 43 | 未披露 | 未持股 | 2025-11-11 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy R. Danker | 男 | Chief Executive Officer and Director | 51 | 348.75万美元 | 未持股 | 2025-11-11 |
| Robert Grant | 男 | President | 40 | 306.38万美元 | 未持股 | 2025-11-11 |
| Ryan M. Clement | 男 | Chief Financial Officer | 44 | 216.77万美元 | 未持股 | 2025-11-11 |
| Stephanie Fisher | 女 | Chief Accounting Officer | 48 | 未披露 | 未持股 | 2025-11-11 |
| William Grant III | 男 | Chief Operating Officer | 50 | 272.40万美元 | 未持股 | 2025-11-11 |
| Sarah Anderson | 女 | Executive Vice President,Healthcare Pharmacy Services | 47 | 未披露 | 未持股 | 2025-11-11 |
| Joshua B. Matthews | 男 | President,Senior Division | 41 | 未披露 | 未持股 | 2025-11-11 |
| Daniel A. Boulware | 男 | Corporate Secretary and General Counsel | 49 | 161.43万美元 | 未持股 | 2025-11-11 |
董事简历
中英对照 | 中文 | 英文- Christopher Wolfe
-
自从我们成立以来，Christopher Wolfe一直是我们的首席财务官。Wolfe先生于2003年至2017年担任中间市场私募股权公司Capital Z Partners的合伙人。他曾负责多个垂直行业的私募股权交易的采购、结构、执行和监控。在2003年加入Capital Z之前，Wolfe先生在Credit Suisse First Boston的并购集团工作。Wolfe先生以优异成绩毕业于Harvard College。
Christopher Wolfe has served as a director of the Company since February 2025. Mr. Wolfe is a Managing Director of Bain Capital Insurance. Prior to joining Bain in 2024, Mr. Wolfe was the Chief Financial Officer of DFB Healthcare Acquisitions Corp., a publicly traded special purpose acquisition company, and certain of its affiliates from January 2018 to June 2023. Prior to that, Mr. Wolfe was a Partner at Capital Z Partners, a private equity fund foced on the financial services indtry, from 2003 to 2017. Mr. Wolfe has served as a member of the Board of Directors of Enhance Health, a privately held health insurance distributor, since February 2024. He previoly served on the board of Permanent General Corp., a direct to consumer insurer, and Universal American Financial Corp., a Medicare Advantage foced insurer. Mr. Wolfe received his AB, magna cum laude, from Harvard College. - 自从我们成立以来，Christopher Wolfe一直是我们的首席财务官。Wolfe先生于2003年至2017年担任中间市场私募股权公司Capital Z Partners的合伙人。他曾负责多个垂直行业的私募股权交易的采购、结构、执行和监控。在2003年加入Capital Z之前，Wolfe先生在Credit Suisse First Boston的并购集团工作。Wolfe先生以优异成绩毕业于Harvard College。
- Christopher Wolfe has served as a director of the Company since February 2025. Mr. Wolfe is a Managing Director of Bain Capital Insurance. Prior to joining Bain in 2024, Mr. Wolfe was the Chief Financial Officer of DFB Healthcare Acquisitions Corp., a publicly traded special purpose acquisition company, and certain of its affiliates from January 2018 to June 2023. Prior to that, Mr. Wolfe was a Partner at Capital Z Partners, a private equity fund foced on the financial services indtry, from 2003 to 2017. Mr. Wolfe has served as a member of the Board of Directors of Enhance Health, a privately held health insurance distributor, since February 2024. He previoly served on the board of Permanent General Corp., a direct to consumer insurer, and Universal American Financial Corp., a Medicare Advantage foced insurer. Mr. Wolfe received his AB, magna cum laude, from Harvard College.
- Timothy R. Danker
-
Tim Danker自2017年起担任公司首席执行官和董事。Danker先生于2016年至2019年担任公司生命部门总裁，于2015年至2016年担任公司生命部门执行Vice President，并于2012年至2015年担任公司汽车与家居部门总裁。在加入该公司之前，Danker先生于2007年至2012年共同创立了Spring Venture Group，并担任其首席执行官，该公司是一家高级梦百合保险分销平台。Danker先生在密苏里大学（University of Missouri）获得工商管理本科学位，并在堪萨斯大学（University of Kansas）获得工商管理硕士学位。
Timothy R. Danker,has served as Chief Executive Officer of the Company and as a director since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co-founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas. - Tim Danker自2017年起担任公司首席执行官和董事。Danker先生于2016年至2019年担任公司生命部门总裁，于2015年至2016年担任公司生命部门执行Vice President，并于2012年至2015年担任公司汽车与家居部门总裁。在加入该公司之前，Danker先生于2007年至2012年共同创立了Spring Venture Group，并担任其首席执行官，该公司是一家高级梦百合保险分销平台。Danker先生在密苏里大学（University of Missouri）获得工商管理本科学位，并在堪萨斯大学（University of Kansas）获得工商管理硕士学位。
- Timothy R. Danker,has served as Chief Executive Officer of the Company and as a director since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co-founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.
- Donald Hawks III
-
Donald Hawks III自2014年以来一直担任公司董事，并于2020年2月被任命为董事长。他自2012年Brookside Equity Partners LLC成立起担任其董事总经理和总裁。他是多家私人公司的董事，包括BEP AUL Holdings LLC、Cash Management Solutions Limited、Hillsdale Furniture Holdings LLC和Ultra Aluminum Manufacturing Inc.。他任职于the Rockefeller Family Fund的投资委员会，是the Fresh Air Fund的董事会成员。Hawks先生在乔治敦大学（Georgetown University）获得本科学位，并在宾夕法尼亚大学沃顿商学院（Wharton School at the University of Pennsylvania）获得工商管理硕士学位。
Donald Hawks III,has served as a director of the Company since 2014 and was appointed to serve as the Chairman of the Board in February 2020. He has served as the President and as a Managing Director of Brookside Equity Partners LLC since its formation in 2012. He is a director of multiple private companies, including Cash Management Solutions Limited. He serves on the Investment Committee of the Rockefeller Family Fund and is a Board Member of the Fresh Air Fund. Mr. Hawks received his undergraduate degree from Georgetown University and his Masters in Business Administration from The Wharton School at the University of Pennsylvania. - Donald Hawks III自2014年以来一直担任公司董事，并于2020年2月被任命为董事长。他自2012年Brookside Equity Partners LLC成立起担任其董事总经理和总裁。他是多家私人公司的董事，包括BEP AUL Holdings LLC、Cash Management Solutions Limited、Hillsdale Furniture Holdings LLC和Ultra Aluminum Manufacturing Inc.。他任职于the Rockefeller Family Fund的投资委员会，是the Fresh Air Fund的董事会成员。Hawks先生在乔治敦大学（Georgetown University）获得本科学位，并在宾夕法尼亚大学沃顿商学院（Wharton School at the University of Pennsylvania）获得工商管理硕士学位。
- Donald Hawks III,has served as a director of the Company since 2014 and was appointed to serve as the Chairman of the Board in February 2020. He has served as the President and as a Managing Director of Brookside Equity Partners LLC since its formation in 2012. He is a director of multiple private companies, including Cash Management Solutions Limited. He serves on the Investment Committee of the Rockefeller Family Fund and is a Board Member of the Fresh Air Fund. Mr. Hawks received his undergraduate degree from Georgetown University and his Masters in Business Administration from The Wharton School at the University of Pennsylvania.
- Earl Devanny III
-
Earl Devanny III于2020年2月被任命为公司董事。Devanny先生自2016年起担任Tract Manager的首席执行官，Tract Manager是一家梦百合战略采购与合规应用套件的提供商。Devanny先生曾于2014年至2016年担任Nuance Communications&；8217；梦百合Business（一家为企业和消费者提供语音和语言解决方案的提供商）的总裁。在此之前，Devanny先生于2010年至2013年担任Trizetto Corporation（一家梦百合信息技术提供商）的董事长兼首席执行官。在此之前，Devanny先生从1999年到2010年担任塞纳公司（一家健康信息技术解决方案、服务、设备和硬件的供应商）的总裁。Mr.Devanny曾担任CommerceBancshares，Inc.的董事Nasdaq:CBSH，Commerce Bank的上市银行控股公司，自2010年以来，他目前还担任Next Health Technologies和McNeil Trusts的董事，这两家公司都是私人公司。Devanny先生在南方大学（University of the South）（Sewanee）获得本科学位。
Earl Devanny III was appointed to serve as a director of the Company in February 2020. Mr. Devanny served as the Chief Executive Officer of Tract Manager, a provider of healthcare strategic scing and compliance application suites, from 2016 until its sale in 2021. Mr. Devanny previoly served as the President of the healthcare biness of Nuance Communications, a provider of voice and language solutions for binesses and consumers, from 2014 to 2016. Prior to that, Mr. Devanny served as the Chairman and Chief Executive Officer of Trizetto Corporation, a healthcare information technology provider, from 2010 to 2013. Prior to that, Mr. Devanny served as the President of Cerner Corporation, a supplier of health information technology solutions, services, devices, and hardware, from 1999 to 2010. From 2010 to April 2025, Mr. Devanny served as a director of Commerce Bancshares, Inc. (NASDAQ: CBSH), the publicly traded bank holding company for Commerce Bank. He currently serves as a director of Accesshealthcare and McNeil Trts, both private companies. Mr. Devanny received his undergraduate degree from the University of the South (Sewanee). - Earl Devanny III于2020年2月被任命为公司董事。Devanny先生自2016年起担任Tract Manager的首席执行官，Tract Manager是一家梦百合战略采购与合规应用套件的提供商。Devanny先生曾于2014年至2016年担任Nuance Communications&；8217；梦百合Business（一家为企业和消费者提供语音和语言解决方案的提供商）的总裁。在此之前，Devanny先生于2010年至2013年担任Trizetto Corporation（一家梦百合信息技术提供商）的董事长兼首席执行官。在此之前，Devanny先生从1999年到2010年担任塞纳公司（一家健康信息技术解决方案、服务、设备和硬件的供应商）的总裁。Mr.Devanny曾担任CommerceBancshares，Inc.的董事Nasdaq:CBSH，Commerce Bank的上市银行控股公司，自2010年以来，他目前还担任Next Health Technologies和McNeil Trusts的董事，这两家公司都是私人公司。Devanny先生在南方大学（University of the South）（Sewanee）获得本科学位。
- Earl Devanny III was appointed to serve as a director of the Company in February 2020. Mr. Devanny served as the Chief Executive Officer of Tract Manager, a provider of healthcare strategic scing and compliance application suites, from 2016 until its sale in 2021. Mr. Devanny previoly served as the President of the healthcare biness of Nuance Communications, a provider of voice and language solutions for binesses and consumers, from 2014 to 2016. Prior to that, Mr. Devanny served as the Chairman and Chief Executive Officer of Trizetto Corporation, a healthcare information technology provider, from 2010 to 2013. Prior to that, Mr. Devanny served as the President of Cerner Corporation, a supplier of health information technology solutions, services, devices, and hardware, from 1999 to 2010. From 2010 to April 2025, Mr. Devanny served as a director of Commerce Bancshares, Inc. (NASDAQ: CBSH), the publicly traded bank holding company for Commerce Bank. He currently serves as a director of Accesshealthcare and McNeil Trts, both private companies. Mr. Devanny received his undergraduate degree from the University of the South (Sewanee).
- Denise Devine
-
Denise Devine于2020年2月担任公司董事，并于2020年9月被任命为薪酬委员会主席。Devine女士是FNB Holdings，LLC（一家致力于健康和保健领域的举措的公司）的创始人，自2014年起担任首席执行官，也是RTM Vital Signs，LLC（一家处于发展阶段的医疗设备公司）的联合创始人兼首席财务官。Devine女士从1994年到2006年还创立并担任Nutripharm，Inc.的首席执行官，该公司产生了成分和工艺专利组合，以创建创新的天然食品，饮料，制药和营养产品。Devine女士此前曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会（American Institute of CPAS）董事会成员。从2005年到2015年，Devine女士担任维拉诺瓦大学（Villanova University）的董事会成员，并担任审计与风险委员会主席。Devine女士自2016年以来一直担任宾夕法尼亚州东南部Ben Franklin Technology Partners的董事会成员。Devine女士自2012年起担任Fulton Financial Corporation（NASDAQ:FULT）董事，自2018年起担任AgroFreshSolutions，Inc.（NASDAQ:AGFS）董事，自2019年起担任立方公司（NYSE:CUB）董事。Devine女士是一名注册会计师，在宾夕法尼亚大学沃顿商学院（Wharton School at the University of Pennsylvania）获得工商管理硕士学位，在维拉诺瓦法学院（Villanova Law School）获得税务硕士学位，在维拉诺瓦大学（Villanova University）获得会计学本科学位。
Denise Devine has served as a director of the Company since February 2020 and was appointed to serve as Chair of the Compensation Committee in September 2020. Ms. Devine is the founder of FNB Holdings, LLC, a company dedicated to initiatives in the health and llness space, of which she has served as Chief Executive Officer since 2014. Ms. Devine is also the Co Founder and Chief Financial Officer of RTM Vital Signs, LLC, a development stage medical device company. Ms. Devine also founded and served as the Chief Executive Officer from 1994 to 2014 of Nutripharm, Inc., a company that has generated a portfolio of composition and process patents to create innovative natural food, beverage, pharmaceutical, and nutraceutical products. Ms. Devine previoly served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs. From 2005 to 2015, Ms. Devine was a member of the Board of Trtees of Villanova University and served as the Chair of the Audit and Risk Committee. Ms. Devine has served on the Board of Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016. Since 2012, Ms. Devine has also served as a director of Fulton Financial Corporation (NASDAQ: FULT), of which she is also the Chair of the Audit Committee, the Vice Chair of the Executive Committee, and a member of the Risk Committee. Since 2025, Ms. Devine has also served as a director of Innovative Solutions & Services, Inc. (NASDAQ: ISSC), where she also serves on the Audit and Compensation Committees. She previoly served as a director, member of the Audit Committee, and Chair of the Compensation and Talent Committee of AgroFresh Solutions, Inc. (NASDAQ: AGFS) from 2018 until its sale in 2023, and as a director of Cubic Corporation (NYSE: CUB) from 2019 until its sale in 2021. Ms. Devine is a Certified Public Accountant and received her Masters in Biness Administration from The Wharton School at the University of Pennsylvania, her Masters in Taxation from Villanova Law School, and her undergraduate degree in Accounting from Villanova University. - Denise Devine于2020年2月担任公司董事，并于2020年9月被任命为薪酬委员会主席。Devine女士是FNB Holdings，LLC（一家致力于健康和保健领域的举措的公司）的创始人，自2014年起担任首席执行官，也是RTM Vital Signs，LLC（一家处于发展阶段的医疗设备公司）的联合创始人兼首席财务官。Devine女士从1994年到2006年还创立并担任Nutripharm，Inc.的首席执行官，该公司产生了成分和工艺专利组合，以创建创新的天然食品，饮料，制药和营养产品。Devine女士此前曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会（American Institute of CPAS）董事会成员。从2005年到2015年，Devine女士担任维拉诺瓦大学（Villanova University）的董事会成员，并担任审计与风险委员会主席。Devine女士自2016年以来一直担任宾夕法尼亚州东南部Ben Franklin Technology Partners的董事会成员。Devine女士自2012年起担任Fulton Financial Corporation（NASDAQ:FULT）董事，自2018年起担任AgroFreshSolutions，Inc.（NASDAQ:AGFS）董事，自2019年起担任立方公司（NYSE:CUB）董事。Devine女士是一名注册会计师，在宾夕法尼亚大学沃顿商学院（Wharton School at the University of Pennsylvania）获得工商管理硕士学位，在维拉诺瓦法学院（Villanova Law School）获得税务硕士学位，在维拉诺瓦大学（Villanova University）获得会计学本科学位。
- Denise Devine has served as a director of the Company since February 2020 and was appointed to serve as Chair of the Compensation Committee in September 2020. Ms. Devine is the founder of FNB Holdings, LLC, a company dedicated to initiatives in the health and llness space, of which she has served as Chief Executive Officer since 2014. Ms. Devine is also the Co Founder and Chief Financial Officer of RTM Vital Signs, LLC, a development stage medical device company. Ms. Devine also founded and served as the Chief Executive Officer from 1994 to 2014 of Nutripharm, Inc., a company that has generated a portfolio of composition and process patents to create innovative natural food, beverage, pharmaceutical, and nutraceutical products. Ms. Devine previoly served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs. From 2005 to 2015, Ms. Devine was a member of the Board of Trtees of Villanova University and served as the Chair of the Audit and Risk Committee. Ms. Devine has served on the Board of Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016. Since 2012, Ms. Devine has also served as a director of Fulton Financial Corporation (NASDAQ: FULT), of which she is also the Chair of the Audit Committee, the Vice Chair of the Executive Committee, and a member of the Risk Committee. Since 2025, Ms. Devine has also served as a director of Innovative Solutions & Services, Inc. (NASDAQ: ISSC), where she also serves on the Audit and Compensation Committees. She previoly served as a director, member of the Audit Committee, and Chair of the Compensation and Talent Committee of AgroFresh Solutions, Inc. (NASDAQ: AGFS) from 2018 until its sale in 2023, and as a director of Cubic Corporation (NYSE: CUB) from 2019 until its sale in 2021. Ms. Devine is a Certified Public Accountant and received her Masters in Biness Administration from The Wharton School at the University of Pennsylvania, her Masters in Taxation from Villanova Law School, and her undergraduate degree in Accounting from Villanova University.
- Raymond Weldon
-
Raymond Weldon自2014年起担任公司董事，并于2016年至2019年担任审计委员会主席。他是Brookside Equity Partners LLC的联合创始人，自2012年成立以来担任其董事总经理之一。Weldon先生从1999年开始受雇于Hillside Capital Incorporated，这是一家私人投资公司，也是Brookside Equity Partners LLC的附属公司，目前担任其董事总经理之一。Weldon先生是一名不活跃的注册会计师，是几家私人公司的董事，包括TJ Acquisition LLC和Hillsdale Furniture LLC。Weldon先生在LaSalle University的荣誉项目获得本科学位，在维拉诺瓦大学（Villanova University）获得税务硕士学位。
Raymond Weldon,has served as a director of the Company since 2014 and as the Chairman of Selectquote, Inc. Audit Committee since 2016. He is a co-founder of Brookside Equity Partners LLC and has served as one of its Managing Directors since its formation in 2012. Mr. Weldon has been employed by Hillside Capital Incorporated, a private investment company and affiliate of Brookside Equity Partners LLC, since 1999 and currently serves as one of its Managing Directors. Mr. Weldon is a Certified Public Accountant (inactive) and is a director of several private companies. Mr. Weldon received his undergraduate degree from the Honors Program of LaSalle University and his Masters in Taxation from Villanova University. - Raymond Weldon自2014年起担任公司董事，并于2016年至2019年担任审计委员会主席。他是Brookside Equity Partners LLC的联合创始人，自2012年成立以来担任其董事总经理之一。Weldon先生从1999年开始受雇于Hillside Capital Incorporated，这是一家私人投资公司，也是Brookside Equity Partners LLC的附属公司，目前担任其董事总经理之一。Weldon先生是一名不活跃的注册会计师，是几家私人公司的董事，包括TJ Acquisition LLC和Hillsdale Furniture LLC。Weldon先生在LaSalle University的荣誉项目获得本科学位，在维拉诺瓦大学（Villanova University）获得税务硕士学位。
- Raymond Weldon,has served as a director of the Company since 2014 and as the Chairman of Selectquote, Inc. Audit Committee since 2016. He is a co-founder of Brookside Equity Partners LLC and has served as one of its Managing Directors since its formation in 2012. Mr. Weldon has been employed by Hillside Capital Incorporated, a private investment company and affiliate of Brookside Equity Partners LLC, since 1999 and currently serves as one of its Managing Directors. Mr. Weldon is a Certified Public Accountant (inactive) and is a director of several private companies. Mr. Weldon received his undergraduate degree from the Honors Program of LaSalle University and his Masters in Taxation from Villanova University.
- Srdjan Vukovic
-
Srdjan Vukovic自2015年以来一直担任我们的董事会成员。Vukovic先生自2018年以来一直担任投资公司Newlight Partners LP的合伙人。在此之前，武科维奇先生于2006年至2018年在索罗斯基金管理公司（Soros Fund Management）工作，在此之前，是美林证券（Merrill Lynch）的分析师。Vukovic先生目前在几家私人公司的董事会任职，包括Zing Health Holdings，Inc.。Vukovic先生此前曾担任Zenium Data Centers的董事会成员，直到2017年该公司被Narragansett Bay Insurance Company收购，直到其被出售并成为一家上市公司的全资子公司，并担任多家私人保险公司的董事会成员。Vukovic先生在纽约大学（New York University）获得金融与精算学士学位。
Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University. - Srdjan Vukovic自2015年以来一直担任我们的董事会成员。Vukovic先生自2018年以来一直担任投资公司Newlight Partners LP的合伙人。在此之前，武科维奇先生于2006年至2018年在索罗斯基金管理公司（Soros Fund Management）工作，在此之前，是美林证券（Merrill Lynch）的分析师。Vukovic先生目前在几家私人公司的董事会任职，包括Zing Health Holdings，Inc.。Vukovic先生此前曾担任Zenium Data Centers的董事会成员，直到2017年该公司被Narragansett Bay Insurance Company收购，直到其被出售并成为一家上市公司的全资子公司，并担任多家私人保险公司的董事会成员。Vukovic先生在纽约大学（New York University）获得金融与精算学士学位。
- Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University.
- Kavita Patel
-
Kavita Patel自2020年以来一直担任我们的董事会成员。Kavita Patel博士是华盛顿特区的执业医师，也是布鲁金斯学会（Brookings Institution）的非居民研究员，在那里她的研究和报告专注于以患者为中心的护理，支付和交付系统以及医疗改革。她此前曾任职奥巴马政府，担任白宫政府间事务和公众参与办公室的政策主管。她还曾担任已故参议员Edward Kennedy的政策分析师和助手。作为卫生部副部长，她是肯尼迪参议员领导下的卫生、教育、劳工和养老金帮助委员会的高级职员的一部分。Patel博士还担任布鲁金斯学会卫生政策中心临床转化的常务董事和约翰霍普金斯卫生系统付款人和提供者战略的Vice President。Patel博士目前在SelectQuote，Inc.公司董事会任职。Patel博士在几个非营利组织的董事会任职，包括Dignity梦百合和SSM梦百合。她在德克萨斯大学健康科学中心获得医学博士学位，在加州大学洛杉矶分校获得医学硕士学位。
Kavita Patel,was appointed to serve as a director of the Company in September 2020. Dr. Patel is a Professor of Medicine at Stanford University and a practicing primary care physician at Mary's Center in Washington, D.C. Dr. Patel has also served as a Venture Partner at New Enterprise Associates since 2017. From 2011–2021, she was a managing director of health care delivery and transformation at the Brookings Institution. Previously, Dr. Patel served as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement in the White House from 2009 to 2010, as Deputy Staff Director on Health on the late Senator Edward Kennedy's staff from 2007 to 2009, and as a member of senior staff of the Senate Health, Education, Labor and Pensions Committee. Dr. Patel has served as a director and member of the Compensation Committee of Arcellx, Inc. (NASDAQ: ACLX) since December 2021. She previously served as a director and member of the Compensation Committee of Sigilon Therapeutics, Inc. (NASDAQ: SGTX) from April 2020 until its sale to Eli Lilly and Company in August 2023; as a director and member of the Governance and Nominating Committee of Tesaro, Inc. (NASDAQ: TSRO) from 2016 until its acquisition by GlaxoSmithKline in 2019; and as a director, member of the Compensation Committee, and Chair of the Nominating and Corporate Governance Committee of Intelligent Medicine Acquisition Corp (NASDAQ: IQMD) from November 2021 to April 2023. Dr. Patel received her undergraduate degree from the University of Texas at Austin, her Master of Public Health from the University of California at Los Angeles, and her medical degree from the University of Texas Health Science Center. - Kavita Patel自2020年以来一直担任我们的董事会成员。Kavita Patel博士是华盛顿特区的执业医师，也是布鲁金斯学会（Brookings Institution）的非居民研究员，在那里她的研究和报告专注于以患者为中心的护理，支付和交付系统以及医疗改革。她此前曾任职奥巴马政府，担任白宫政府间事务和公众参与办公室的政策主管。她还曾担任已故参议员Edward Kennedy的政策分析师和助手。作为卫生部副部长，她是肯尼迪参议员领导下的卫生、教育、劳工和养老金帮助委员会的高级职员的一部分。Patel博士还担任布鲁金斯学会卫生政策中心临床转化的常务董事和约翰霍普金斯卫生系统付款人和提供者战略的Vice President。Patel博士目前在SelectQuote，Inc.公司董事会任职。Patel博士在几个非营利组织的董事会任职，包括Dignity梦百合和SSM梦百合。她在德克萨斯大学健康科学中心获得医学博士学位，在加州大学洛杉矶分校获得医学硕士学位。
- Kavita Patel,was appointed to serve as a director of the Company in September 2020. Dr. Patel is a Professor of Medicine at Stanford University and a practicing primary care physician at Mary's Center in Washington, D.C. Dr. Patel has also served as a Venture Partner at New Enterprise Associates since 2017. From 2011–2021, she was a managing director of health care delivery and transformation at the Brookings Institution. Previously, Dr. Patel served as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement in the White House from 2009 to 2010, as Deputy Staff Director on Health on the late Senator Edward Kennedy's staff from 2007 to 2009, and as a member of senior staff of the Senate Health, Education, Labor and Pensions Committee. Dr. Patel has served as a director and member of the Compensation Committee of Arcellx, Inc. (NASDAQ: ACLX) since December 2021. She previously served as a director and member of the Compensation Committee of Sigilon Therapeutics, Inc. (NASDAQ: SGTX) from April 2020 until its sale to Eli Lilly and Company in August 2023; as a director and member of the Governance and Nominating Committee of Tesaro, Inc. (NASDAQ: TSRO) from 2016 until its acquisition by GlaxoSmithKline in 2019; and as a director, member of the Compensation Committee, and Chair of the Nominating and Corporate Governance Committee of Intelligent Medicine Acquisition Corp (NASDAQ: IQMD) from November 2021 to April 2023. Dr. Patel received her undergraduate degree from the University of Texas at Austin, her Master of Public Health from the University of California at Los Angeles, and her medical degree from the University of Texas Health Science Center.
- Srdjan Vukovic
-
Srdjan Vukovic，自2025年2月起担任公司董事。武科维奇先生是私人投资公司Sava Hill的合伙人。2018年至2025年6月，他是私募股权公司Newlight Partners LP的合伙人。在此之前，武科维奇先生曾任职于索罗斯基金管理公司，曾任美林证券分析师。Vukovic先生目前担任私人健康保险公司Zing Health和行为健康公司服务提供商Jade Health的董事会成员。Vukovic Previoly先生曾在上市的初级保健提供商Oak Street Health的董事会任职，直到该公司于2023年被CVS收购；Zenium Data Centers，直到2017年被上市的CyrOne收购；Narragansett Bay Insurance Company，直到该公司被出售并成为上市的Heritage Insurance Holdings, Inc.的全资子公司；以及多家私营保险公司。Vukovic先生获得了纽约大学的金融和精算科学学士学位。
Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University. - Srdjan Vukovic，自2025年2月起担任公司董事。武科维奇先生是私人投资公司Sava Hill的合伙人。2018年至2025年6月，他是私募股权公司Newlight Partners LP的合伙人。在此之前，武科维奇先生曾任职于索罗斯基金管理公司，曾任美林证券分析师。Vukovic先生目前担任私人健康保险公司Zing Health和行为健康公司服务提供商Jade Health的董事会成员。Vukovic Previoly先生曾在上市的初级保健提供商Oak Street Health的董事会任职，直到该公司于2023年被CVS收购；Zenium Data Centers，直到2017年被上市的CyrOne收购；Narragansett Bay Insurance Company，直到该公司被出售并成为上市的Heritage Insurance Holdings, Inc.的全资子公司；以及多家私营保险公司。Vukovic先生获得了纽约大学的金融和精算科学学士学位。
- Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University.
高管简历
中英对照 | 中文 | 英文- Timothy R. Danker
Tim Danker自2017年起担任公司首席执行官和董事。Danker先生于2016年至2019年担任公司生命部门总裁，于2015年至2016年担任公司生命部门执行Vice President，并于2012年至2015年担任公司汽车与家居部门总裁。在加入该公司之前，Danker先生于2007年至2012年共同创立了Spring Venture Group，并担任其首席执行官，该公司是一家高级梦百合保险分销平台。Danker先生在密苏里大学（University of Missouri）获得工商管理本科学位，并在堪萨斯大学（University of Kansas）获得工商管理硕士学位。
Timothy R. Danker,has served as Chief Executive Officer of the Company and as a director since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co-founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.- Tim Danker自2017年起担任公司首席执行官和董事。Danker先生于2016年至2019年担任公司生命部门总裁，于2015年至2016年担任公司生命部门执行Vice President，并于2012年至2015年担任公司汽车与家居部门总裁。在加入该公司之前，Danker先生于2007年至2012年共同创立了Spring Venture Group，并担任其首席执行官，该公司是一家高级梦百合保险分销平台。Danker先生在密苏里大学（University of Missouri）获得工商管理本科学位，并在堪萨斯大学（University of Kansas）获得工商管理硕士学位。
- Timothy R. Danker,has served as Chief Executive Officer of the Company and as a director since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co-founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.
- Robert Grant
Robert Grant自2019年以来一直担任该公司高级部门总裁。格兰特先生此前曾于2017年至2019年担任公司首席营收官。在此之前，格兰特先生于2016年至2017年担任公司人寿部门的销售高级副总裁，并于2013年至2016年担任公司高级部门的销售和运营总监。Grant先生在堪萨斯大学（University of Kansas）获得本科学位。格兰特先生是公司董事会副主席William Grant II的儿子，也是公司首席运营官William Grant III的兄弟。
Robert Grant,has served as the President of the Company since October 2021. Mr. Grant previously served as the President of the Company's Senior Division from 2019 to 2021; the Company's Chief Revenue Officer from 2017 to 2019; the Senior Vice President of Sales of the Company's Life Division from 2016 to 2017; and as the Director of Sales and Operations for the Company's Senior Division from 2013 to 2016. Mr. Grant received his undergraduate degree from the University of Kansas.- Robert Grant自2019年以来一直担任该公司高级部门总裁。格兰特先生此前曾于2017年至2019年担任公司首席营收官。在此之前，格兰特先生于2016年至2017年担任公司人寿部门的销售高级副总裁，并于2013年至2016年担任公司高级部门的销售和运营总监。Grant先生在堪萨斯大学（University of Kansas）获得本科学位。格兰特先生是公司董事会副主席William Grant II的儿子，也是公司首席运营官William Grant III的兄弟。
- Robert Grant,has served as the President of the Company since October 2021. Mr. Grant previously served as the President of the Company's Senior Division from 2019 to 2021; the Company's Chief Revenue Officer from 2017 to 2019; the Senior Vice President of Sales of the Company's Life Division from 2016 to 2017; and as the Director of Sales and Operations for the Company's Senior Division from 2013 to 2016. Mr. Grant received his undergraduate degree from the University of Kansas.
- Ryan M. Clement
Ryan M.Clement自2022年6月起担任公司临时首席财务官。在被任命为临时CFO之前，Clement先生于2022年1月至2022年5月担任公司财务规划与分析高级副总裁。Clement先生在加入公司之前，于2019年至2022年在基于SaaS的私营软件技术公司Sifted，LLC（前身为VeriShip）担任首席财务官。2012年至2016年，Clement先生担任The Mutual Fund Store财务副总裁，负责财务规划和分析，并在并购中发挥核心作用。继2016年将The Mutual Fund Store出售给上市的独立注册投资顾问Financial Engines, Inc.后，克莱门特曾在Financial Engines担任分销策略副总裁，后在2018年Financial Engines合并后担任该公司与爱德曼金融服务公司的整合主管。Clement先生拥有密苏里大学房地产和金融与银行业务的工商管理硕士学位和双学士学位。
Ryan M. Clement,has served as the Company's Chief Financial Officer since February 2023. Mr. Clement joined the Company in January 2022 as the Senior Vice President of Financial Planning & Analysis and was appointed Interim Chief Financial Officer in June 2022. Before joining the Company, Mr. Clement was the Chief Financial Officer of Sifted, LLC (formerly VeriShip), a private SaaS-based software technology firm, from 2019 to 2022. From 2012 to 2016, Mr. Clement was Vice President of Finance at The Mutual Fund Store, where he was responsible for financial planning and analysis and played a central role in M&A. Following the sale of The Mutual Fund Store in 2016 to Financial Engines, Inc., a publicly-traded independent registered investment adviser, Mr. Clement served as Vice President of Distribution Strategy at Financial Engines and later oversaw its integration with Edelman Financial Services as Head of Integration following the entities' merger in 2018. Mr. Clement holds an MBA and a dual B.S. in Real Estate and Finance & Banking from the University of Missouri.- Ryan M.Clement自2022年6月起担任公司临时首席财务官。在被任命为临时CFO之前，Clement先生于2022年1月至2022年5月担任公司财务规划与分析高级副总裁。Clement先生在加入公司之前，于2019年至2022年在基于SaaS的私营软件技术公司Sifted，LLC（前身为VeriShip）担任首席财务官。2012年至2016年，Clement先生担任The Mutual Fund Store财务副总裁，负责财务规划和分析，并在并购中发挥核心作用。继2016年将The Mutual Fund Store出售给上市的独立注册投资顾问Financial Engines, Inc.后，克莱门特曾在Financial Engines担任分销策略副总裁，后在2018年Financial Engines合并后担任该公司与爱德曼金融服务公司的整合主管。Clement先生拥有密苏里大学房地产和金融与银行业务的工商管理硕士学位和双学士学位。
- Ryan M. Clement,has served as the Company's Chief Financial Officer since February 2023. Mr. Clement joined the Company in January 2022 as the Senior Vice President of Financial Planning & Analysis and was appointed Interim Chief Financial Officer in June 2022. Before joining the Company, Mr. Clement was the Chief Financial Officer of Sifted, LLC (formerly VeriShip), a private SaaS-based software technology firm, from 2019 to 2022. From 2012 to 2016, Mr. Clement was Vice President of Finance at The Mutual Fund Store, where he was responsible for financial planning and analysis and played a central role in M&A. Following the sale of The Mutual Fund Store in 2016 to Financial Engines, Inc., a publicly-traded independent registered investment adviser, Mr. Clement served as Vice President of Distribution Strategy at Financial Engines and later oversaw its integration with Edelman Financial Services as Head of Integration following the entities' merger in 2018. Mr. Clement holds an MBA and a dual B.S. in Real Estate and Finance & Banking from the University of Missouri.
- Stephanie Fisher
Stephanie Fisher自2020年8月起担任公司首席会计官。在加入公司之前，Fisher女士曾在YRC Worldwide，Inc.（纳斯达克股票代码：YELL）（现Yellow Corporation）是一家北美零担运输公司，担任首席财务官，领导公司对财务和运营职能进行战略转型。在2017年被任命为首席财务官之前，Fisher女士曾在YRC担任过十多年的其他高级会计职位，包括副总裁副总裁兼财务总监和财务报告总监。Fisher女士在获得堪萨斯州立大学工商管理学士学位和会计学硕士学位后，在安永会计师事务所开始了她的职业生涯。
Stephanie Fisher,has served as the Company's Chief Accounting Officer since August 2020. Prior to joining the Company, Ms. Fisher was the Chief Financial Officer of YRC Worldwide, Inc. (NASDAQ: YELL) (now Yellow Corporation), a North American less-than-truckload transportation company, where she led a strategic transformation of the company's finance and operations functions. Before her appointment as Chief Financial Officer in 2017, Ms. Fisher spent over a decade in various senior-level accounting positions at YRC, including Vice President & Controller and Director of Financial Reporting. Ms. Fisher began her career in the Assurance practice of Ernst & Young LLP after earning her B.S. in Business Administration and Master of Accountancy from Kansas State University.- Stephanie Fisher自2020年8月起担任公司首席会计官。在加入公司之前，Fisher女士曾在YRC Worldwide，Inc.（纳斯达克股票代码：YELL）（现Yellow Corporation）是一家北美零担运输公司，担任首席财务官，领导公司对财务和运营职能进行战略转型。在2017年被任命为首席财务官之前，Fisher女士曾在YRC担任过十多年的其他高级会计职位，包括副总裁副总裁兼财务总监和财务报告总监。Fisher女士在获得堪萨斯州立大学工商管理学士学位和会计学硕士学位后，在安永会计师事务所开始了她的职业生涯。
- Stephanie Fisher,has served as the Company's Chief Accounting Officer since August 2020. Prior to joining the Company, Ms. Fisher was the Chief Financial Officer of YRC Worldwide, Inc. (NASDAQ: YELL) (now Yellow Corporation), a North American less-than-truckload transportation company, where she led a strategic transformation of the company's finance and operations functions. Before her appointment as Chief Financial Officer in 2017, Ms. Fisher spent over a decade in various senior-level accounting positions at YRC, including Vice President & Controller and Director of Financial Reporting. Ms. Fisher began her career in the Assurance practice of Ernst & Young LLP after earning her B.S. in Business Administration and Master of Accountancy from Kansas State University.
- William Grant III
William Grant III，自2019年起担任SelectQuote，公司首席运营官。Grant先生此前曾于2017年至2019年担任SelectQuote，Inc.首席营销官兼SelectQuote，Inc.高级部门总裁，并于2012年至2017年担任SelectQuote，Inc.高级部门营销高级副总裁。格兰特先生获得了堪萨斯大学的本科学位。
William Grant III,has served as SelectQuote, Inc. Chief Operating Officer since 2019. Mr. Grant previously served as SelectQuote, Inc. Chief Marketing Officer and President of SelectQuote, Inc. Senior Division from 2017 to 2019 and as the Senior Vice President of Marketing for SelectQuote, Inc. Senior Division from 2012 to 2017. Mr. Grant received his undergraduate degree from the University of Kansas.- William Grant III，自2019年起担任SelectQuote，公司首席运营官。Grant先生此前曾于2017年至2019年担任SelectQuote，Inc.首席营销官兼SelectQuote，Inc.高级部门总裁，并于2012年至2017年担任SelectQuote，Inc.高级部门营销高级副总裁。格兰特先生获得了堪萨斯大学的本科学位。
- William Grant III,has served as SelectQuote, Inc. Chief Operating Officer since 2019. Mr. Grant previously served as SelectQuote, Inc. Chief Marketing Officer and President of SelectQuote, Inc. Senior Division from 2017 to 2019 and as the Senior Vice President of Marketing for SelectQuote, Inc. Senior Division from 2012 to 2017. Mr. Grant received his undergraduate degree from the University of Kansas.
- Sarah Anderson
Sarah Anderson，自2024年7月起担任药房服务执行副总裁。安德森女士于2018年加入公司，担任高级部门营销高级总监，曾担任多个高级营销和运营职位，包括营销运营高级副总裁和医疗保健执行副总裁。从2002 – 2018年，安德森女士曾任职于斯普林特公司（现T-Mobile US），担任财务、营销和运营等多个职务。安德森女士在圣安东尼奥三一大学就读后，在德克萨斯州休斯顿的安然公司开始了她的职业生涯。
Sarah Anderson,has served as the Executive Vice President of Pharmacy Services since July 2024. Ms. Anderson joined the Company in 2018 as the Senior Director of Marketing for the Senior division and has held a variety of senior marketing and operations positions, including Senior Vice President of Marketing Operations and Executive Vice President of Healthcare. From 2002–2018, Ms. Anderson worked for Sprint Corporation (now T-Mobile US) in multiple roles across finance, marketing, and operations. Ms. Anderson began her professional career at Enron Corporation in Houston, Texas after attending Trinity University in San Antonio.- Sarah Anderson，自2024年7月起担任药房服务执行副总裁。安德森女士于2018年加入公司，担任高级部门营销高级总监，曾担任多个高级营销和运营职位，包括营销运营高级副总裁和医疗保健执行副总裁。从2002 – 2018年，安德森女士曾任职于斯普林特公司（现T-Mobile US），担任财务、营销和运营等多个职务。安德森女士在圣安东尼奥三一大学就读后，在德克萨斯州休斯顿的安然公司开始了她的职业生涯。
- Sarah Anderson,has served as the Executive Vice President of Pharmacy Services since July 2024. Ms. Anderson joined the Company in 2018 as the Senior Director of Marketing for the Senior division and has held a variety of senior marketing and operations positions, including Senior Vice President of Marketing Operations and Executive Vice President of Healthcare. From 2002–2018, Ms. Anderson worked for Sprint Corporation (now T-Mobile US) in multiple roles across finance, marketing, and operations. Ms. Anderson began her professional career at Enron Corporation in Houston, Texas after attending Trinity University in San Antonio.
- Joshua B. Matthews
Joshua B. Matthews，自2022年7月起担任公司高级部门总裁。Matthews先生于2014年首次加入公司，曾在高级部门担任多个行政职务，包括销售高级副总裁，并于2019年7月至2022年6月担任医疗保险销售运营执行副总裁。Matthews先生在堪萨斯州立大学获得工商管理本科学位，在罗克赫斯特大学获得数学硕士学位。
Joshua B. Matthews,has served as the President of the Company's Senior division since July 2022. Mr. Matthews first joined the Company in 2014 and has served in several executive positions within the Senior division, including Senior Vice President of Sales and, from July 2019 to June 2022, Executive Vice President of Medicare Sales Operations. Mr. Matthews received his undergraduate degree in Business Administration from Kansas State University and his Masters in Mathematics from Rockhurst University.- Joshua B. Matthews，自2022年7月起担任公司高级部门总裁。Matthews先生于2014年首次加入公司，曾在高级部门担任多个行政职务，包括销售高级副总裁，并于2019年7月至2022年6月担任医疗保险销售运营执行副总裁。Matthews先生在堪萨斯州立大学获得工商管理本科学位，在罗克赫斯特大学获得数学硕士学位。
- Joshua B. Matthews,has served as the President of the Company's Senior division since July 2022. Mr. Matthews first joined the Company in 2014 and has served in several executive positions within the Senior division, including Senior Vice President of Sales and, from July 2019 to June 2022, Executive Vice President of Medicare Sales Operations. Mr. Matthews received his undergraduate degree in Business Administration from Kansas State University and his Masters in Mathematics from Rockhurst University.
- Daniel A. Boulware
Daniel A. Boulware自2019年10月起担任公司总法律顾问兼秘书。Boulware先生在加入公司之前担任SS & C Health的副总裁兼总法律顾问，该公司是SS & C Technologies Holdings，Inc.的医疗保健部门，该公司是一家向金融服务行业提供技术的上市公司，向药房福利管理、医疗索赔处理、数据分析以及医疗保健行业提供相关技术的上市公司。Boulware先生的职业生涯始于2002年，当时他是Polsinelli PC的一名合伙人，并于2012年成为该公司的股东。Boulware先生在堪萨斯大学获得本科学位、法学博士学位和工商管理硕士学位。
Daniel A. Boulware has served as the Company's General Counsel and Secretary since October 2019. Prior to joining the Company, Mr. Boulware was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc., a public company providing technology to the financial services indtry and pharmacy benefit management, medical claims processing, data analytics, and other technology to the healthcare indtry. Mr. Boulware began his career in 2002 as an Associate at Polsinelli PC, where he was made Shareholder in 2012. Mr. Boulware earned his undergraduate degree, Juris Doctor and Master of Biness Administration from the University of Kansas.- Daniel A. Boulware自2019年10月起担任公司总法律顾问兼秘书。Boulware先生在加入公司之前担任SS & C Health的副总裁兼总法律顾问，该公司是SS & C Technologies Holdings，Inc.的医疗保健部门，该公司是一家向金融服务行业提供技术的上市公司，向药房福利管理、医疗索赔处理、数据分析以及医疗保健行业提供相关技术的上市公司。Boulware先生的职业生涯始于2002年，当时他是Polsinelli PC的一名合伙人，并于2012年成为该公司的股东。Boulware先生在堪萨斯大学获得本科学位、法学博士学位和工商管理硕士学位。
- Daniel A. Boulware has served as the Company's General Counsel and Secretary since October 2019. Prior to joining the Company, Mr. Boulware was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc., a public company providing technology to the financial services indtry and pharmacy benefit management, medical claims processing, data analytics, and other technology to the healthcare indtry. Mr. Boulware began his career in 2002 as an Associate at Polsinelli PC, where he was made Shareholder in 2012. Mr. Boulware earned his undergraduate degree, Juris Doctor and Master of Biness Administration from the University of Kansas.